mRNA combination vaccines for respiratory infections: the developer’s view

“...combining targets by symptoms allows for a more integrated approach to seasonal vaccination campaigns...”Charlotte Barker, Commissioning Editor, Vaccine Insights, catches up with Francesca Ceddia, Chief Medical Affairs Officer, Moderna, to learn more about the company’s efforts to develop mRNA-based combination vaccines against COVID-19, RSV, and influenza.

Institutions

Publication Details

Journal
Vaccine Insights
Published
2025-02-19
DOI
https://doi.org/10.18609/vac.2025.003
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

mRNA combination vaccines for respiratory infections: the developer’s view

Vaccine Insights
RNA Interference and Gene Delivery
article

mRNA combination vaccines for respiratory infections: the developer’s view

article en

Abstract

“...combining targets by symptoms allows for a more integrated approach to seasonal vaccination campaigns...”Charlotte Barker, Commissioning Editor, Vaccine Insights, catches up with Francesca Ceddia, Chief Medical Affairs Officer, Moderna, to learn more about the company’s efforts to develop mRNA-based combination vaccines against COVID-19, RSV, and influenza.

Vaccine InsightsVol. 4(1)
Moderna Therapeutics (United States) (US)
Openalex Percentile: Top 37%
RNA Interference and Gene Delivery
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

mRNA combination vaccines for respiratory infections: the developer’s view · Vaccine Insights (2025) | TGRS Research Map | TGRS